Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Simply Wall StAug 17 09:11 ET

Despite Selling Recently, Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Insiders Own 38% Stake and Recent Decline Might Have Cost Them

Simply Wall StAug 15 08:57 ET

RBC Capital Maintains Verrica Pharmaceuticals(VRCA.US) With Buy Rating, Cuts Target Price to $13

Moomoo NewsAug 15 06:31 ET · Ratings

Analysts Conflicted on These Healthcare Names: Verrica Pharmaceuticals (VRCA), Celcuity (CELC) and Bluebird Bio (BLUE)

TipRanksAug 15 06:30 ET · Ratings

Verrica Pharmaceuticals Is Maintained at Buy by Needham

Dow JonesAug 15 05:39 ET

Verrica Pharmaceuticals Analyst Ratings

BenzingaAug 15 05:28 ET · Ratings